Oligodendrogenesis in iron-deficient rats: effect of apotransferrin

J Neurosci Res. 2010 Jun;88(8):1695-707. doi: 10.1002/jnr.22348.

Abstract

In rats, iron deficiency produces an alteration in myelin formation. However, there is limited information on the effects of this condition on oligodendroglial cell (OLGc) proliferation and maturation. In the present study, we further analyzed the hypomyelination associated with iron deficiency by studying the dynamics of oligodendrogenesis. Rats were fed control (40 mg Fe/kg) or iron-deficient (4 mg Fe/kg) diets from gestation day 5 until postnatal day 3 (P3) or 11 (P11). OLGc proliferation, migration and differentiation were investigated before and after an intracranial injection of apotransferrin at 3 days of age (P3). The proliferating cell population was evaluated at P3. Iron-deficient (ID) animals showed an increase in the oligodendrocyte precursors cell (OPC) population in comparison with controls. The overall pattern of migration of cells labeled with BrdU was investigated at P11. Iron deficiency increased the amount of BrdU(+) cells in the corpus callosum (CC) and decreased OLGc maturation and myelin formation. Changes in nerve conduction were analyzed by measuring visual evoked potentials. Latency and amplitude were significantly disturbed in ID rats compared with controls. Both parameters were substantially normalized when animals were treated with a single intracranial injection of 350 ng apotransferrin (aTf). The current results give support to the idea that iron deficiency increases the number of proliferating and undifferentiated cells in the CC compared with the control. Treatment with aTf almost completely reverted the effects of iron deficiency, both changing the migration pattern and increasing the number of mature cells in the CC and myelin formation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Apoproteins / metabolism
  • Apoproteins / therapeutic use*
  • Basic Helix-Loop-Helix Transcription Factors / metabolism
  • Body Weight / physiology
  • Brain
  • Bromodeoxyuridine / metabolism
  • Cell Count
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology
  • Cell Proliferation / drug effects*
  • Corpus Callosum / metabolism
  • Corpus Callosum / pathology
  • Demyelinating Diseases / drug therapy*
  • Demyelinating Diseases / etiology
  • Demyelinating Diseases / pathology*
  • Demyelinating Diseases / physiopathology
  • Electroencephalography / methods
  • Evoked Potentials, Visual / drug effects
  • Evoked Potentials, Visual / physiology
  • Female
  • Gene Expression Regulation, Developmental / drug effects
  • Gene Expression Regulation, Developmental / physiology
  • Hematocrit / methods
  • Iron Deficiencies*
  • Myelin Basic Protein / metabolism
  • Nerve Tissue Proteins / metabolism
  • Neural Cell Adhesion Molecule L1 / metabolism
  • Oligodendroglia / drug effects*
  • Oligodendroglia / physiology
  • Photic Stimulation / methods
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Proliferating Cell Nuclear Antigen / metabolism
  • Rats
  • Sialic Acids / metabolism
  • Transferrin / metabolism
  • Transferrin / therapeutic use*

Substances

  • Apoproteins
  • Basic Helix-Loop-Helix Transcription Factors
  • Myelin Basic Protein
  • Nerve Tissue Proteins
  • Neural Cell Adhesion Molecule L1
  • Olig1 protein, rat
  • Proliferating Cell Nuclear Antigen
  • Sialic Acids
  • Transferrin
  • apotransferrin
  • polysialyl neural cell adhesion molecule
  • Bromodeoxyuridine